Drug maker Imprimis Pharmaceuticals just found a backer to distribute its $1 alternative to Daraprim, the infection-fighting drug whose price was hiked 5,000% by Turing Pharmaceuticals.
Express Scripts (ESRX), a major manager of prescription drugs, announced Tuesday that it will offer patients the low-cost Imprimis drug, instead of Daraprim, starting as soon as this week.
Express Scripts partners with maker of $1 Turing alternative - Dec. 1, 2015
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.